You have 9 free searches left this month | for more free features.

Interferon Inducers

Showing 1 - 25 of 1,694

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 tablets
  • +2 more
  • Jinan, Shandong, China
    Shandong Provincial Hospital
Aug 30, 2023

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 18, 2021

Treatment of Influenza and ARVI in Children by Kagocel ®

Completed
  • Influenza
  • Acute Upper Respiratory Infection
  • Saint-Petersburg, Russian Federation
    Research Institute of Children's Infections of the Federal Medic
Dec 2, 2020

Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

Completed
  • Prostate Cancer
  • Intratumoral (IT) Poly ICLC 0.5 mg
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2022

Malaria Trial (Ganaplacide, Lumefantrine, Efavirenz)

Completed
  • Malaria
  • Belfast, Northern Ireland, United Kingdom
    Novartis Investigative Site
Jan 11, 2023

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Atrial Fibrillation, Thromboembolism, Venous Trial in Roma (DOACs)

Recruiting
  • Atrial Fibrillation
  • Thromboembolism, Venous
  • Roma, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Feb 20, 2023

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

Recruiting
  • AIDS
  • Hepatitis B
  • Peginterferon alfa-2b Injection
  • Guangzhou, Guangdong, China
    Guangzhou Eighth People's Hospital, Guangzhou Medical University
Aug 10, 2023

Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and

Recruiting
  • Lymphomatoid Granulomatosis
  • +3 more
  • Interferon
  • Rituxan and EPOCH
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma, Metastatic Non-Cutaneous Melanoma Trial in Canada, Ireland, United

Active, not recruiting
  • Metastatic Cutaneous Melanoma
  • +15 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +582 more
Jan 28, 2023

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Hepatocellular Carcinoma, Chronic Hepatitis B Trial in Xiamen (NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined

Recruiting
  • Hepatocellular Carcinoma
  • Chronic Hepatitis B
  • NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined with interferon treatments
  • NAs ("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") treatments
  • Xiamen, Fujian, China
    Boheng Zhang
Feb 7, 2023

Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)

Recruiting
  • Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Birmingham, Alabama
  • +106 more
Jan 13, 2023

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

Multiple Sclerosis Trial in Cairo (Blood sample collection)

Recruiting
  • Multiple Sclerosis
  • Blood sample collection
  • Cairo, Egypt
    Nasser Institute for Research and Treatment
Feb 21, 2023

Mycobacterium Abscessus Infection in Chronic Lung Disease and

Enrolling by invitation
  • Mycobacterium Abscessus Infection
  • +2 more
  • Appropriate treatment
  • Pathum Wan, Bangkok, Thailand
    King Chulalongkorn Memorial Hospital
Aug 31, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

Not yet recruiting
  • Membranous Nephropathy
  • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
  • Nice, France
    CHU de NICE
Jul 4, 2023

AERD - Aspirin Exacerbated Respiratory Disease Trial in Kraków (Aspirin 300 Mg Oral Tablet, Placebo)

Recruiting
  • AERD - Aspirin Exacerbated Respiratory Disease
  • Aspirin 300 Mg Oral Tablet
  • Placebo
  • Kraków, Poland
    University Hospital, Pulmunology Clinic
Apr 4, 2023

IFN? and Inflammatory Mediators in Hemophagocytic

Completed
  • Hemophagocytic Lymphohistiocytoses
  • Blood Draws Data Collection
  • Boston, Massachusetts
    Brigham and Women's Hospital
Sep 14, 2023

Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

Active, not recruiting
  • Metastatic Myxoid Liposarcoma
  • +15 more
  • Interferon Gamma-1b
  • +2 more
  • Palo Alto, California
  • +6 more
Aug 2, 2022

Venetoclax in Patients With Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 27, 2021

Venetoclax in Patients With Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 27, 2021